JAKSA SR 15MG TAB

JAKSA SR 15MG TAB contains Upadacitinib, a selective JAK inhibitor designed to provide targeted relief for inflammatory conditions. This extended-release formulation delivers consistent therapeutic levels throughout the day, supporting improved joint function and reduced inflammation. Suitable for adult patients requiring effective inflammation management. Always follow your healthcare provider's dosage instructions and consult regarding any existing medical conditions or medications before use.